This May Be Pfizer's Key to Long-Term Vaccine Dominance

This May Be Pfizer's Key to Long-Term Vaccine Dominance

Source: 
Motley Fool
snippet: 
  • Pfizer is already the leader in the coronavirus vaccine market.
  • The company predicts its vaccine will generate $32 billion in revenue this year.
  • A candidate in development may address one of today’s biggest challenges, and that could equal lasting dominance.